{"nctId":"NCT02355886","briefTitle":"Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy","startDateStruct":{"date":"2015-04-22","type":"ACTUAL"},"conditions":["Bladder Carcinoma"],"count":25,"armGroups":[{"label":"Arm I (gabapentin)","type":"EXPERIMENTAL","interventionNames":["Drug: Gabapentin","Other: Questionnaire Administration"]},{"label":"Arm II (placebo)","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo","Other: Questionnaire Administration"]}],"interventions":[{"name":"Gabapentin","otherNames":["Gralise","Neurontin"]},{"name":"Placebo","otherNames":["placebo therapy","PLCB","sham therapy"]},{"name":"Questionnaire Administration","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosis of bladder cancer\n* Anticipated radical cystectomy with ileal conduit or orthotopic neobladder\n\nExclusion Criteria:\n\n* Presence of spinal cord injury including any form of paraplegia or quadriplegia\n* Allergy to gabapentin\n* Active alcohol dependence, defined as 2 or more positive questions on the CAGE alcoholism questionnaire\n* Illicit drug use (excluding recreational marijuana)\n* Chronic kidney disease with glomerular filtration rate \\< 30 ml/min\n* Pregnancy: All female patients \\< 55 years old (yo) will be administered a urine pregnancy test prior to enrollment\n* Non-English speaking patients\n* Chronic gabapentin, or the similar drug pregabalin, use\n* Chronic narcotic use (daily or near daily use for \\> 90 days)","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Patient Total Equivalent Analgesic Requirement (Morphine Equivalents)","description":"Geometric Mean and Standard Deviation of patient total equivalent analgesic","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"297.65","spread":"179.95"},{"groupId":"OG001","value":"396.16","spread":"149.84"}]}]}]},{"type":"SECONDARY","title":"Length of Stay Following Radical Cystectomy","description":"The two study groups will be compared by Length of stay following radical cystectomy","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.58","spread":"1.98"},{"groupId":"OG001","value":"6.73","spread":"2.83"}]}]}]},{"type":"SECONDARY","title":"Patient Self-assessed Pain on Numerical Pain Scale","description":"The two study groups compared on Patient self-assessed pain on numerical pain likert scale. Numeric Pain Scale was utilized with values of 0-10 with increasing severity.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.15","spread":"2.8"},{"groupId":"OG001","value":"7.67","spread":"1.89"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":13},"commonTop":["nausea","sedation"]}}}